Compounds for treating cystic fibrosis
Résumé
The present invention relates to compounds of Formula ( I ) or pharmaceutically acceptable enantiomers, salts, solvates or prodrugs thereof. The invention further relates to the use of the compounds of Formula ( I ) for the treatment of cystic fibrosis. The invention also relates to a process for manufacturing compounds of Formula ( I ).